Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

Midas B. Mulder; Erwin Birnie; Caroline van Dijck-van Boetzelaer; Gert-Jan van de Geijn; Egbert Boeve; Elsbeth M. Westerman; Paul Hamberg

doi:10.1080/0284186X.2020.1862908

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

Midas B. Mulder^*, Erwin Birnie, Caroline van Dijck-van Boetzelaer, Gert-Jan van de Geijn, Egbert Boeve, Elsbeth M. Westerman, Paul Hamberg

^*Corresponding author for this work

Health Psychology Research (HPR)

Research output: Contribution to journal › Letter › Academic › peer-review

88 Downloads (Pure)

Original language	English
Pages (from-to)	539-543
Number of pages	5
Journal	ACTA ONCOLOGICA
Volume	60
Issue number	4
Early online date	26-Dec-2020
DOIs	https://doi.org/10.1080/0284186X.2020.1862908
Publication status	Published - 2021

Keywords

SERUM TESTOSTERONE
INTERMITTENT
NORMALIZATION
SUPPRESSION
CASTRATION
CARCINOMA
ESTROGEN
KINETICS

Access to Document

10.1080/0284186X.2020.1862908

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancerFinal publisher's version, 1.03 MBLicence: Taverne

Handle.net

Persistent link

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)
Mulder, M. B. (Contributor), Birnie, E. (Creator), van Dijck–van Boetzelaer, C. (Contributor), van de Geijn, G.-J. (Contributor), Boevé, E. (Creator), Westerman, E. M. (Creator) & Hamberg, P. (Creator), Taylor & Francis Group, 26-Dec-2020
DOI: 10.6084/m9.figshare.13489432, https://tandf.figshare.com/articles/dataset/Unsafe_testosterone-based_dosing_regimen_of_androgen_deprivation_therapy_in_patients_with_locally_advanced_or_metastatic_prostate_cancer_a_prematurely_ended_randomized_controlled_trial_MIDAS-trial_/13489432
Dataset

Cite this

Mulder, M. B., Birnie, E., van Dijck-van Boetzelaer, C., van de Geijn, G.-J., Boeve, E., Westerman, E. M., & Hamberg, P. (2021). Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial). ACTA ONCOLOGICA, 60(4), 539-543. https://doi.org/10.1080/0284186X.2020.1862908

@article{cf125cbb809a4177bc2a0702f5d3c5bc,

title = "Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)",

keywords = "SERUM TESTOSTERONE, INTERMITTENT, NORMALIZATION, SUPPRESSION, CASTRATION, CARCINOMA, ESTROGEN, KINETICS",

author = "Mulder, {Midas B.} and Erwin Birnie and {van Dijck-van Boetzelaer}, Caroline and {van de Geijn}, Gert-Jan and Egbert Boeve and Westerman, {Elsbeth M.} and Paul Hamberg",

year = "2021",

doi = "10.1080/0284186X.2020.1862908",

language = "English",

volume = "60",

pages = "539--543",

journal = "ACTA ONCOLOGICA",

issn = "0284-186X",

publisher = "Taylor & Francis Ltd",

number = "4",

}

Mulder, MB, Birnie, E, van Dijck-van Boetzelaer, C, van de Geijn, G-J, Boeve, E, Westerman, EM & Hamberg, P 2021, 'Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)', ACTA ONCOLOGICA, vol. 60, no. 4, pp. 539-543. https://doi.org/10.1080/0284186X.2020.1862908

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial). / Mulder, Midas B.; Birnie, Erwin; van Dijck-van Boetzelaer, Caroline et al.
In: ACTA ONCOLOGICA, Vol. 60, No. 4, 2021, p. 539-543.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer

T2 - a prematurely ended randomized controlled trial (MIDAS-trial)

AU - Mulder, Midas B.

AU - Birnie, Erwin

AU - van Dijck-van Boetzelaer, Caroline

AU - van de Geijn, Gert-Jan

AU - Boeve, Egbert

AU - Westerman, Elsbeth M.

AU - Hamberg, Paul

PY - 2021

Y1 - 2021

KW - SERUM TESTOSTERONE

KW - INTERMITTENT

KW - NORMALIZATION

KW - SUPPRESSION

KW - CASTRATION

KW - CARCINOMA

KW - ESTROGEN

KW - KINETICS

U2 - 10.1080/0284186X.2020.1862908

DO - 10.1080/0284186X.2020.1862908

M3 - Letter

C2 - 33356721

SN - 0284-186X

VL - 60

SP - 539

EP - 543

JO - ACTA ONCOLOGICA

JF - ACTA ONCOLOGICA

IS - 4

ER -

Mulder MB, Birnie E, van Dijck-van Boetzelaer C, van de Geijn GJ, Boeve E, Westerman EM et al. Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial). ACTA ONCOLOGICA. 2021;60(4):539-543. Epub 2020 Dec 26. doi: 10.1080/0284186X.2020.1862908

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

Keywords

Access to Document

Handle.net

Datasets

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

Cite this